PIK3C3 and pulmonary fibrosis: However, a pharmacological inhibitor of PIK3C3, PIK-III, but not SAR405 or autophinib, demonstrated anti-fibrotic effects in dermal and lung fibroblasts as well as in animal models of skin and lung fibrosis (Figs 1, 3 and 4).